These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 22647257)

  • 1. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
    Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
    J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort.
    Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I
    Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
    Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
    J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
    Sleegers K; Brouwers N; Van Damme P; Engelborghs S; Gijselinck I; van der Zee J; Peeters K; Mattheijssens M; Cruts M; Vandenberghe R; De Deyn PP; Robberecht W; Van Broeckhoven C
    Ann Neurol; 2009 May; 65(5):603-9. PubMed ID: 19288468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
    Gómez-Tortosa E; Guerrero-López R; Gil-Neciga E; Franco E; del Ser T; Jiménez Escrig A; Pérez-Pérez J; Sainz MJ
    Eur J Neurol; 2013 Sep; 20(9):1319-24. PubMed ID: 23724906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.
    Carecchio M; Fenoglio C; De Riz M; Guidi I; Comi C; Cortini F; Venturelli E; Restelli I; Cantoni C; Bresolin N; Monaco F; Scarpini E; Galimberti D
    J Neurol Sci; 2009 Dec; 287(1-2):291-3. PubMed ID: 19683260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
    Brouwers N; Nuytemans K; van der Zee J; Gijselinck I; Engelborghs S; Theuns J; Kumar-Singh S; Pickut BA; Pals P; Dermaut B; Bogaerts V; De Pooter T; Serneels S; Van den Broeck M; Cuijt I; Mattheijssens M; Peeters K; Sciot R; Martin JJ; Cras P; Santens P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; Sleegers K
    Arch Neurol; 2007 Oct; 64(10):1436-46. PubMed ID: 17923627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.
    Moreno F; Indakoetxea B; Barandiaran M; Alzualde A; Gabilondo A; Estanga A; Ruiz J; Ruibal M; Bergareche A; Martí-Massó JF; López de Munain A
    Neurology; 2009 Oct; 73(17):1367-74. PubMed ID: 19858458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum progranulin predicts the presence of mutations: a prospective study.
    Schofield EC; Halliday GM; Kwok J; Loy C; Double KL; Hodges JR
    J Alzheimers Dis; 2010; 22(3):981-4. PubMed ID: 20858962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.
    Piscopo P; Rivabene R; Galimberti D; Crestini A; Talarico G; Vanacore N; Scarpini E; Bruno G; Confaloni A
    J Alzheimers Dis; 2013; 35(2):313-8. PubMed ID: 23396349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
    Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
    Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.
    Ghidoni R; Benussi L; Glionna M; Franzoni M; Binetti G
    Neurology; 2008 Oct; 71(16):1235-9. PubMed ID: 18768919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losing protein in the brain: the case of progranulin.
    Ghidoni R; Paterlini A; Albertini V; Binetti G; Benussi L
    Brain Res; 2012 Oct; 1476():172-82. PubMed ID: 22348647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration.
    Borroni B; Bonvicini C; Galimberti D; Tremolizzo L; Papetti A; Archetti S; Turla M; Alberici A; Agosti C; Premi E; Appollonio I; Rainero I; Ferrarese C; Gennarelli M; Scarpini E; Padovani A
    Neurobiol Aging; 2011 Mar; 32(3):555.e1-8. PubMed ID: 20947212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor protein regulates the penetrance of frontotemporal lobar degeneration in progranulin mutation carriers.
    Ghidoni R; Flocco R; Paterlini A; Glionna M; Caruana L; Tonoli E; Binetti G; Benussi L
    J Alzheimers Dis; 2014; 38(3):533-9. PubMed ID: 24018267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.